Home > Income Statement > GLAND PHARMA

GLAND PHARMA
Revenue

    Back to Income Statement
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Sales ₹5,617 Cr₹5,665 Cr₹3,625 Cr₹4,401 Cr₹3,463 Cr

What is the latest Revenue of GLAND PHARMA ?

The latest Revenue ratio of GLAND PHARMA is ₹5,617 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹5,617 Cr
Mar2025₹5,665 Cr
Mar2024₹3,625 Cr
Mar2023₹4,401 Cr
Mar2022₹3,463 Cr

How is Revenue of GLAND PHARMA Trending?

Years Revenue % Change
Mar2026 ₹5,617 Cr
-0.85
Mar2025 ₹5,665 Cr
56.29
Mar2024 ₹3,625 Cr
-17.64
Mar2023 ₹4,401 Cr
27.08
Mar2022 ₹3,463 Cr -

Compare Revenue of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹42,907.4 Cr 0.9% 5.3% 26.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹467,630.0 Cr -0.1% 0.5% 14% Stock Analytics
DIVIS LABORATORIES ₹218,972.0 Cr -0.9% 21.1% 25.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,358.0 Cr -1.3% 1.1% 32.7% Stock Analytics
CIPLA ₹118,916.0 Cr 0.2% 2.1% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹97,824.0 Cr 0.2% -7.7% -7.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

0.9%

5.3%

26.7%

SENSEX

0.5%

2.6%

-3.7%


You may also like the below Video Courses